Tag: TCT
Interventional News’ top 10 most popular stories of November 2021
November’s top 10 features a pilot study regarding cryoablation for the treatment of early-stage, low-risk breast tumours, as well as data indicating that the Ellipsys vascular access...
Twelve-month PARADIGM study data demonstrate benefit of CGuard Embolic Prevention System...
InspireMD has announced 12-month follow up data from PARADIGM-101 study of the CGuard Embolic Prevention System (EPS), which were presented at the Transcatheter Cardiovascular...
